These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1649426)

  • 1. [Hepatitis C virus antibody in Hungarian blood donors, persons at risk and patients with post-transfusion hepatitis].
    Héjjas M; Mihály I; Tücsök A; Nagy G; Hajnal A; Medgyesi G; Hollán Z
    Orv Hetil; 1991 Jun; 132(23):1235-8. PubMed ID: 1649426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reactivity of hepatitis C virus (HCV) antibody among blood donors in Hungary].
    Héjjas M; Medgyesi G; Hajnal A
    Orv Hetil; 1992 Jul; 133 Suppl 1():21-4. PubMed ID: 1321394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Post-transfusional hepatitis in the city of Campinas, SP, Brazil. II. Presence of anti-HBc and anti-HCV antibodies in blood donor candidates and occurrence of post-transfusional hepatitis C in recipients of blood or derivates].
    Gonçales Júnior FL; Pedro Rde J; da Silva LJ; Boccato RS; Gonçales NS
    Rev Inst Med Trop Sao Paulo; 1993; 35(1):63-71. PubMed ID: 7506447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated post-transfusion serum transaminase values associated with a highly significant trend for increasing prevalence of anti-Vesivirus antibody in Korean patients.
    Lee H; Cho YH; Park JS; Kim EC; Smith AW; Ko G
    J Med Virol; 2012 Dec; 84(12):1943-52. PubMed ID: 23080501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The declining risk of post-transfusion hepatitis C virus infection.
    Donahue JG; Muñoz A; Ness PM; Brown DE; Yawn DH; McAllister HA; Reitz BA; Nelson KE
    N Engl J Med; 1992 Aug; 327(6):369-73. PubMed ID: 1320736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis C virus antibody in the serum of blood donors].
    Barna TK; Ozsvár Z; Szendrényi V; Gál G
    Orv Hetil; 1996 Mar; 137(10):507-11. PubMed ID: 8713664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Viral hepatitis and blood transfusion].
    Larsen J; Hetland G; Skaug K; Maeland A
    Tidsskr Nor Laegeforen; 1991 Mar; 111(7):825-8. PubMed ID: 1850559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
    Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
    Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays.
    Aach RD; Stevens CE; Hollinger FB; Mosley JW; Peterson DA; Taylor PE; Johnson RG; Barbosa LH; Nemo GJ
    N Engl J Med; 1991 Nov; 325(19):1325-9. PubMed ID: 1656258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Occurrence of antibodies against hepatitis C virus (anti-HCV) in patients on long-term hemodialysis].
    Sułowicz W; Dolezal M; Hejmo D; Gerhardt E; Ignacak E
    Przegl Lek; 1992; 49(1-2):67-8. PubMed ID: 1333622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
    Ouzan D; Pesle B; Baldini E; Rimbourg H; Darphin F; Cohen N; Brichetti A; Follana R
    Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of antibody to hepatitis C virus in blood donors, high-risk groups and patients with liver diseases in Hungary. A multicentre study using ABBOTT EIA test and a comparison with an ORTHO ELISA test system.
    Pár A; Kántor I; Barcsay E; Hollós I; Mezey I; Brojnás J; Takács M; Héjjas M; Illés M; Szontágh L
    Acta Med Hung; 1991; 48(3-4):167-76. PubMed ID: 1726611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey.
    Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R
    Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
    Alter HJ; Purcell RH; Shih JW; Melpolder JC; Houghton M; Choo QL; Kuo G
    N Engl J Med; 1989 Nov; 321(22):1494-500. PubMed ID: 2509915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated risk of transmission of hepatitis C virus by blood transfusion.
    Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B
    Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation.
    Olotu AA; Oyelese AO; Salawu L; Audu RA; Okwuraiwe AP; Aboderin AO
    Virol J; 2016 May; 13():76. PubMed ID: 27150469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antibodies to hepatitis C virus and other markers in Jamaica.
    King SD; Dodd RY; Haynes G; Wynter HH; Sullivan MT; Serjeant GR; Choo-Kang E; Michael E
    West Indian Med J; 1995 Jun; 44(2):55-7. PubMed ID: 7545339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.